Mo Ebrahimkhani

Mo Ebrahimkhani is a distinguished academic and industry leader in the fields of biotechnology, synthetic biology, and regenerative medicine. Currently serving as Co-Founder and Chief Scientific Officer of a stealth startup and Orgagen Biosciences, along with Co-Founding responsibilities at Genexgen, Ebrahimkhani also holds the position of Associate Professor with tenure at the University of Pittsburgh, where involvement spans multiple departments relating to pathology and bioengineering. Previously, Ebrahimkhani contributed to medical education as an Adjunct Assistant Professor at Mayo Clinic School of Medicine and an Assistant Professor at Arizona State University. Ebrahimkhani’s extensive research experience includes roles at the Massachusetts Institute of Technology, with a focus on human organoids and tissue engineering, and postdoctoral work in immunology. Ebrahimkhani earned a Doctor of Medicine from Tehran University of Medical Sciences and completed postdoctoral studies at MIT, enhancing expertise in complex biological systems and regenerative technologies.